Radiographic Progression of Structural Joint Damage in Patients With Active Psoriatic Arthritis Treated With Ixekizumab Over 52 Weeks

SKIN The Journal of Cutaneous Medicine
doi 10.25251/skin.1.supp.27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Society for Cutaneous Medicine

Related search

Adipocytokines Are Associated With Radiographic Joint Damage in Rheumatoid Arthritis

Arthritis & Rheumatism
2009English

Radiographic Progression According to Baseline C-Reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Patients Treated With Tofacitinib or Adalimumab

Journal of Rheumatology
RheumatologyAllergyImmunology
2019English

Inhibition of Radiographic Progression Across Levels of Composite Index-Defined Disease Activity in Patients With Active Psoriatic Arthritis Treated With Intravenous Golimumab: Results From a Phase-3, Double-Blind, Placebo-Controlled Trial

Arthritis Research & Therapy
2020English

Ixekizumab: Targeting Plaque Psoriasis and Psoriatic Arthritis

Prescriber
Pharmacology
2019English

The Association Between Sonographic Enthesitis and Radiographic Damage in Psoriatic Arthritis

Arthritis Research & Therapy
2017English

AB0223 Prognostic Factors for Radiographic Damage in Patients With Seronegative Rheumatoid Arthritis

2017English

Peripheral Neuropathy in Patients With Psoriatic Arthritis

ScienceRise: Medical Science
2019English

Cardiovascular Risk in Patients With Psoriatic Arthritis

Terapevticheskii Arkhiv
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Pss13 - Budget Impact Analysis of Apremilast in Patients With Active Psoriatic Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy